{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T17:16:11Z","timestamp":1788369371121,"version":"build-2803163510"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003521","name":"Department of Education, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003521","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Office for Health and Medical Research, Australian Government"},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2033228"],"award-info":[{"award-number":["2033228"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vitamin D receptor (VDR) regulates musculoskeletal biology, but its adult, tissue-specific roles are difficult to resolve with germline or conventional conditional knockouts. We developed recombinant adeno-associated viral vectors (rAAVs) to drive Cre recombinase selectively in bone or muscle and used them to delete\n                    <jats:italic>Vdr<\/jats:italic>\n                    postnatally in\n                    <jats:italic>Vdr<\/jats:italic>\n                    <jats:sup>\n                      <jats:italic>fl\/fl<\/jats:italic>\n                    <\/jats:sup>\n                    mice. To engineer a muscle-selective vector, we screened AAV9 constructs carrying candidate muscle promoters and identified tMCK\u039463 as the most selective\u00a0promoter. Packaging this cassette in the myotropic AAVMYO capsid further reduced off-target skeletal expression while preserving strong muscle transduction. Local intramuscular delivery of AAVMYO\u2013tMCK\u039463 enabled unilateral targeting with minimal systemic spread. In parallel, a bone-selective AAV8-Sp7 vector supported skeletal delivery. These vectors produced tissue-restricted\n                    <jats:italic>Vdr<\/jats:italic>\n                    deletion in\n                    <jats:italic>Vdr<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>muscle<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:sup>\n                      <jats:italic>AAV<\/jats:italic>\n                    <\/jats:sup>\n                    and\n                    <jats:italic>Vdr<\/jats:italic>\n                    <jats:sub>\n                      <jats:italic>bone<\/jats:italic>\n                    <\/jats:sub>\n                    <jats:sup>\n                      <jats:italic>AAV<\/jats:italic>\n                    <\/jats:sup>\n                    mice. Muscle-targeted VDR loss reduced grip strength (\u20139.27%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.01) and endurance (\u201316.58%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05). Bone-targeted deletion caused modest but significant skeletal changes, including increased cortical thickness (\u2009+\u20097%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.05) and higher vertebral stiffness (\u2009+\u200927%,\n                    <jats:italic>p<\/jats:italic>\n                    \u2009&lt;\u20090.001), without effects on body weight or tibial strength. This scalable, crossbreeding-independent strategy enables compartment-specific functional studies in floxed models, including genes with embryonic lethality or complex tissue interactions. It also provides a general framework for iterative capsid-promoter optimization to maximize specificity in vivo across diverse tissues.\n                  <\/jats:p>","DOI":"10.1038\/s41434-026-00636-y","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:03:08Z","timestamp":1785344588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bone- and muscle-targeted adeno-associated viral vectors enable tissue-selective vitamin D receptor knockdown in mice"],"prefix":"10.1038","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2267-3671","authenticated-orcid":false,"given":"Alexandra K.","family":"O\u2019Donohue","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Norris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsien-Yin","family":"Kao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucinda R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny E.","family":"Gunton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,29]]},"reference":[{"key":"636_CR1","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.3390\/nu14142847","volume":"14","author":"N Rochel","year":"2022","unstructured":"Rochel N. Vitamin D and its receptor from a structural perspective. Nutrients. 2022;14:2847.","journal-title":"Nutrients"},{"key":"636_CR2","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i1.20","volume":"8","author":"C Carlberg","year":"1998","unstructured":"Carlberg C, Polly P. Gene regulation by vitamin D3. Crit Rev Eukaryot Gene Expr. 1998;8:19\u201342.","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"636_CR3","doi-asserted-by":"publisher","first-page":"5186","DOI":"10.3390\/nu14235186","volume":"14","author":"N Latic","year":"2022","unstructured":"Latic N, Erben RG. Interaction of Vitamin D with peptide hormones with emphasis on parathyroid hormone, FGF23, and the renin-angiotensin-aldosterone system. Nutrients. 2022;14:5186.","journal-title":"Nutrients"},{"key":"636_CR4","doi-asserted-by":"publisher","first-page":"398","DOI":"10.3390\/nu16030398","volume":"16","author":"C Carlberg","year":"2024","unstructured":"Carlberg C, Velleuer E. Vitamin D and aging: central role of immunocompetence. Nutrients. 2024;16:398.","journal-title":"Nutrients"},{"key":"636_CR5","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.jdiacomp.2017.12.002","volume":"32","author":"A Neelankal John","year":"2018","unstructured":"Neelankal John A, Jiang FX. An overview of type 2 diabetes and the importance of vitamin D3-vitamin D receptor interaction in pancreatic \u03b2-cells. J Diab Complicat. 2018;32:429\u201343.","journal-title":"J Diab Complicat"},{"key":"636_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110355","volume":"96","author":"SE Bollen","year":"2022","unstructured":"Bollen SE, Bass JJ, Fujita S, Wilkinson D, Hewison M, Atherton PJ. The Vitamin D\/Vitamin D receptor (VDR) axis in muscle atrophy and sarcopenia. Cell Signal. 2022;96:110355.","journal-title":"Cell Signal"},{"key":"636_CR7","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1186\/s13018-023-04320-4","volume":"18","author":"Y Li","year":"2023","unstructured":"Li Y, Zhao P, Jiang B, Liu K, Zhang L, Wang H, et al. Modulation of the vitamin D\/vitamin D receptor system in osteoporosis pathogenesis: insights and therapeutic approaches. J Orthop Surg Res. 2023;18:860.","journal-title":"J Orthop Surg Res"},{"key":"636_CR8","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1038\/ng0897-391","volume":"16","author":"T Yoshizawa","year":"1997","unstructured":"Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet. 1997;16:391\u20136.","journal-title":"Nat Genet"},{"key":"636_CR9","doi-asserted-by":"publisher","first-page":"9831","DOI":"10.1073\/pnas.94.18.9831","volume":"94","author":"YC Li","year":"1997","unstructured":"Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci USA. 1997;94:9831\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"636_CR10","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1210\/en.2012-1542","volume":"154","author":"Y Yamamoto","year":"2013","unstructured":"Yamamoto Y, Yoshizawa T, Fukuda T, Shirode-Fukuda Y, Yu T, Sekine K, et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. Endocrinology. 2013;154:1008\u201320.","journal-title":"Endocrinology"},{"key":"636_CR11","doi-asserted-by":"publisher","first-page":"5138","DOI":"10.1210\/en.2003-0502","volume":"144","author":"I Endo","year":"2003","unstructured":"Endo I, Inoue D, Mitsui T, Umaki Y, Akaike M, Yoshizawa T, et al. Deletion of vitamin D receptor gene in mice results in abnormal skeletal muscle development with deregulated expression of myoregulatory transcription factors. Endocrinology. 2003;144:5138\u201344.","journal-title":"Endocrinology"},{"key":"636_CR12","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1007\/s00223-015-0054-x","volume":"97","author":"CM Girgis","year":"2015","unstructured":"Girgis CM, Cha KM, Houweling PJ, Rao R, Mokbel N, Lin M, et al. Vitamin D receptor ablation and vitamin D deficiency result in reduced grip strength, altered muscle fibers, and increased myostatin in mice. Calcif Tissue Int. 2015;97:602\u201310.","journal-title":"Calcif Tissue Int"},{"key":"636_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/jcsm.12460","volume":"10","author":"CM Girgis","year":"2019","unstructured":"Girgis CM, Cha KM, So B, Tsang M, Chen J, Houweling PJ, et al. Mice with myocyte deletion of vitamin D receptor have sarcopenia and impaired muscle function. J Cachexia, Sarcopenia Muscle. 2019;10:1228\u201340.","journal-title":"J Cachexia, Sarcopenia Muscle"},{"key":"636_CR14","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1079\/BJN20041325","volume":"93","author":"TS Chau","year":"2005","unstructured":"Chau TS, Lai WP, Cheung PY, Favus MJ, Wong MS. Age-related alteration of vitamin D metabolism in response to low-phosphate diet in rats. Br J Nutr. 2005;93:299\u2013307.","journal-title":"Br J Nutr"},{"key":"636_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2022.116636","volume":"167","author":"AK O\u2019Donohue","year":"2023","unstructured":"O\u2019Donohue AK, Xiao Y, Lee LR, Schofield T, Cheng TL, Munns CF, et al. Targeted postnatal knockout of Sclerostin using a bone-targeted adeno-associated viral vector increases bone anabolism and decreases canalicular density. Bone. 2023;167:116636.","journal-title":"Bone"},{"key":"636_CR16","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.omtm.2019.08.010","volume":"15","author":"LR Lee","year":"2019","unstructured":"Lee LR, Peacock L, Lisowski L, Little DG, Munns CF, Schindeler A. Targeting adeno-associated virus vectors for local delivery to fractures and systemic delivery to the skeleton. Mol Ther Methods Clin Dev. 2019;15:101\u201311.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"636_CR17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.cardiores.2005.12.017","volume":"70","author":"OJ M\u00fcller","year":"2006","unstructured":"M\u00fcller OJ, Leuchs B, Pleger ST, Grimm D, Franz WM, Katus HA, et al. Improved cardiac gene transfer by transcriptional and transductional targeting of adeno-associated viral vectors. Cardiovasc Res. 2006;70:70\u20138.","journal-title":"Cardiovasc Res"},{"key":"636_CR18","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1038\/sj.gt.3303029","volume":"14","author":"B Bostick","year":"2007","unstructured":"Bostick B, Ghosh A, Yue Y, Long C, Duan D. Systemic AAV-9 transduction in mice is influenced by animal age but not by the route of administration. Gene Ther. 2007;14:1605\u20139.","journal-title":"Gene Ther"},{"key":"636_CR19","doi-asserted-by":"publisher","first-page":"1944","DOI":"10.1038\/mt.2008.207","volume":"16","author":"Y Yue","year":"2008","unstructured":"Yue Y, Ghosh A, Long C, Bostick B, Smith BF, Kornegay JN, et al. A single intravenous injection of adeno-associated virus serotype-9 leads to whole body skeletal muscle transduction in dogs. Mol Ther. 2008;16:1944\u201352.","journal-title":"Mol Ther"},{"key":"636_CR20","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1089\/hum.2019.173","volume":"31","author":"L Muraine","year":"2020","unstructured":"Muraine L, Bensalah M, Dhiab J, Cordova G, Arandel L, Marhic A, et al. Transduction efficiency of adeno-associated virus serotypes after local injection in mouse and human skeletal muscle. Hum Gene Ther. 2020;31:233\u201340.","journal-title":"Hum Gene Ther"},{"key":"636_CR21","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/mt.2011.287","volume":"20","author":"A Asokan","year":"2012","unstructured":"Asokan A, Schaffer DV, Samulski RJ. The AAV vector toolkit: poised at the clinical crossroads. Mol Ther. 2012;20:699\u2013708.","journal-title":"Mol Ther"},{"key":"636_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19230-w","volume":"11","author":"J Weinmann","year":"2020","unstructured":"Weinmann J, Weis S, Sippel J, Tulalamba W, Remes A, El Andari J, et al. Identification of a myotropic AAV by massively parallel in vivo evaluation of barcoded capsid variants. Nat Commun. 2020;11:5432.","journal-title":"Nat Commun"},{"key":"636_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-08283-7","volume":"10","author":"S Sarcar","year":"2019","unstructured":"Sarcar S, Tulalamba W, Rincon MY, Tipanee J, Pham HQ, Evens H, et al. Next-generation muscle-directed gene therapy by in silico vector design. Nat Commun. 2019;10:492.","journal-title":"Nat Commun"},{"key":"636_CR24","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1038\/gt.2008.104","volume":"15","author":"B Wang","year":"2008","unstructured":"Wang B, Li J, Fu FH, Chen C, Zhu X, Zhou L, et al. Construction and analysis of compact muscle-specific promoters for AAV vectors. Gene Ther. 2008;15:1489\u201399.","journal-title":"Gene Ther"},{"key":"636_CR25","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.omtm.2019.09.001","volume":"15","author":"K Piekarowicz","year":"2019","unstructured":"Piekarowicz K, Bertrand AT, Azibani F, Beuvin M, Julien L, Machowska M, et al. A muscle hybrid promoter as a novel tool for gene therapy. Mol Ther Methods Clin Dev. 2019;15:157\u201369.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"636_CR26","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41434-019-0106-3","volume":"27","author":"W Tulalamba","year":"2020","unstructured":"Tulalamba W, Weinmann J, Pham QH, El Andari J, VandenDriessche T, Chuah MK, et al. Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors. Gene Ther. 2020;27:170\u20139.","journal-title":"Gene Ther"},{"key":"636_CR27","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nn.2467","volume":"13","author":"L Madisen","year":"2010","unstructured":"Madisen L, Zwingman TA, Sunkin SM, Oh SW, Zariwala HA, Gu H, et al. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain. Nat Neurosci. 2010;13:133\u201340.","journal-title":"Nat Neurosci"},{"key":"636_CR28","doi-asserted-by":"publisher","first-page":"13324","DOI":"10.1073\/pnas.231474698","volume":"98","author":"SJ Van Cromphaut","year":"2001","unstructured":"Van Cromphaut SJ, Dewerchin M, Hoenderop JG, Stockmans I, Van Herck E, Kato S, et al. Duodenal calcium absorption in vitamin D receptor-knockout mice: functional and molecular aspects. Proc Natl Acad Sci USA. 2001;98:13324\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"636_CR29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.32607\/actanaturae.11063","volume":"13","author":"VV Skopenkova","year":"2021","unstructured":"Skopenkova VV, Egorova TV, Bardina MV. Muscle-specific promoters for gene therapy. Acta Nat. 2021;13:47\u201358.","journal-title":"Acta Nat"},{"key":"636_CR30","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/sj.mt.6300027","volume":"15","author":"MZ Salva","year":"2007","unstructured":"Salva MZ, Himeda CL, Tai PW, Nishiuchi E, Gregorevic P, Allen JM, et al. Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle. Mol Ther. 2007;15:320\u20139.","journal-title":"Mol Ther"},{"key":"636_CR31","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-1-61737-982-6_1","volume":"709","author":"CL Himeda","year":"2011","unstructured":"Himeda CL, Chen X, Hauschka SD. Design and testing of regulatory cassettes for optimal activity in skeletal and cardiac muscles. Methods Mol Biol. 2011;709:3\u201319.","journal-title":"Methods Mol Biol"},{"key":"636_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","volume":"108","author":"H Niwa","year":"1991","unstructured":"Niwa H, Yamamura K, Miyazaki J. Efficient selection for high-expression transfectants with a novel eukaryotic vector. Gene. 1991;108:193\u20139.","journal-title":"Gene"},{"key":"636_CR33","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1038\/gt.2010.157","volume":"18","author":"C Qiao","year":"2011","unstructured":"Qiao C, Yuan Z, Li J, He B, Zheng H, Mayer C, et al. Liver-specific microRNA-122 target sequences incorporated in AAV vectors efficiently inhibit transgene expression in the liver. Gene Ther. 2011;18:403\u201310.","journal-title":"Gene Ther"},{"key":"636_CR34","first-page":"119","volume":"99","author":"JC Grieger","year":"2005","unstructured":"Grieger JC, Samulski RJ. Adeno-associated virus as a gene therapy vector: vector development, production and clinical applications. Adv Biochem Eng Biotechnol. 2005;99:119\u201345.","journal-title":"Adv Biochem Eng Biotechnol"},{"key":"636_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-7-17","volume":"7","author":"JH Choi","year":"2014","unstructured":"Choi JH, Yu NK, Baek GC, Bakes J, Seo D, Nam HJ, et al. Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons. Mol Brain. 2014;7:17.","journal-title":"Mol Brain"},{"key":"636_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01473-x","volume":"11","author":"J Yasa","year":"2023","unstructured":"Yasa J, Reed CE, Bournazos AM, Evesson FJ, Pang I, Graham ME, et al. Minimal expression of dysferlin prevents development of dysferlinopahty in dysferlin exon 40a knockout mice. Acta Neuropathologica Commun. 2023;11:15.","journal-title":"Acta Neuropathologica Commun"},{"key":"636_CR37","doi-asserted-by":"publisher","first-page":"F1192","DOI":"10.1152\/ajprenal.00360.2009","volume":"297","author":"T Meir","year":"2009","unstructured":"Meir T, Levi R, Lieben L, Libutti S, Carmeliet G, Bouillon R, et al. Deletion of the vitamin D receptor specifically in the parathyroid demonstrates a limited role for the receptor in parathyroid physiology. Am J Physiol Ren Physiol. 2009;297:F1192\u2013F1198.","journal-title":"Am J Physiol Ren Physiol"},{"key":"636_CR38","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.jsbmb.2017.06.002","volume":"177","author":"SM Lee","year":"2018","unstructured":"Lee SM, Meyer MB, Benkusky NA, O\u2019Brien CA, Pike JW. The impact of VDR expression and regulation in vivo. J Steroid Biochem Mol Biol. 2018;177:36\u201345.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"636_CR39","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1002\/gene.20104","volume":"41","author":"JC Chen","year":"2005","unstructured":"Chen JC, Mortimer J, Marley J, Goldhamer DJ. MyoD-cre transgenic mice: a model for conditional mutagenesis and lineage tracing of skeletal muscle. Genesis. 2005;41:116\u201321.","journal-title":"Genesis"},{"key":"636_CR40","doi-asserted-by":"publisher","first-page":"e27","DOI":"10.1093\/nar\/27.19.e27","volume":"27","author":"P Miniou","year":"1999","unstructured":"Miniou P, Tiziano D, Frugier T, Roblot N, Le Meur M, Melki J. Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Res. 1999;27:e27.","journal-title":"Nucleic Acids Res"},{"key":"636_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/2044-5040-2-8","volume":"2","author":"JJ McCarthy","year":"2012","unstructured":"McCarthy JJ, Srikuea R, Kirby TJ, Peterson CA, Esser KA. Inducible Cre transgenic mouse strain for skeletal muscle-specific gene targeting. Skelet Muscle. 2012;2:8. May 7.","journal-title":"Skelet Muscle"},{"key":"636_CR42","doi-asserted-by":"publisher","first-page":"1576","DOI":"10.1038\/sj.gt.3301829","volume":"9","author":"K Yuasa","year":"2002","unstructured":"Yuasa K, Sakamoto M, Miyagoe-Suzuki Y, Tanouchi A, Yamamoto H, Li J, et al. Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product. Gene Ther. 2002;9:1576\u201388.","journal-title":"Gene Ther"},{"key":"636_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2025.101451","volume":"33","author":"TJ McGowan","year":"2025","unstructured":"McGowan TJ, Lewerenz N, Maino E, Th\u00fcrkauf M, J\u00f6rin L, R\u00fcegg MA. AAV capsids target muscle-resident cells with different efficiencies-A comparative study between AAV8, AAVMYO, and AAVMYO2. Mol Ther Methods Clin Dev. 2025;33:101451.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"636_CR44","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/j.omtm.2020.09.016","volume":"19","author":"JB Kwon","year":"2020","unstructured":"Kwon JB, Ettyreddy AR, Vankara A, Bohning JD, Devlin G, Hauschka SD, et al. In vivo gene editing of muscle stem cells with adeno-associated viral vectors in a mouse model of Duchenne muscular dystrophy. Mol Ther Methods Clin Dev. 2020;19:320\u20139.","journal-title":"Mol Ther Methods Clin Dev"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00636-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00636-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00636-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T18:15:20Z","timestamp":1785521720000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41434-026-00636-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,29]]},"references-count":44,"alternative-id":["636"],"URL":"https:\/\/doi.org\/10.1038\/s41434-026-00636-y","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,29]]},"assertion":[{"value":"12 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"LRL is employed by Broken String Biosciences. DG is the co-founder and shareholder of primAAVera Therapeutics GmbH. These affiliations did not influence the study design, data collection, analysis, or interpretation. All other authors declare no conflict of interest.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Animal studies were approved by the Animal Ethics Committee of The Children\u2019s Hospital at Westmead\/Children\u2019s Medical Research Institute (Protocol K382), and the Western Sydney Local Health District Animal Ethics Committee (Protocol 4360). All procedures were performed in accordance with the Australian code for the care and use of animals for scientific purposes.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}